ACE and peripheral arterial disease: In this retrospective cohort study conducted in 40,000 individuals with diabetes treated with either ACE inhibitors or ARBs, the risk of foot ulcer, and the risk of lower limb amputation for those with peripheral arterial disease were both twice higher for those on ACE inhibitors.